• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MECKI 评分倡议:发展与现状。

The MECKI score initiative: Development and state of the art.

机构信息

Centro Cardiologico Monzino, IRCCS, Italy.

Cardiology Division, Cardiac Arrhythmia Centre and Cardiomyopathies Unit, San Camillo-Forlanini Hospital, Italy.

出版信息

Eur J Prev Cardiol. 2020 Dec;27(2_suppl):5-11. doi: 10.1177/2047487320959010.

DOI:10.1177/2047487320959010
PMID:33238744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7691632/
Abstract

The high morbidity and poor survival rates associated with chronic heart failure still represent a big challenge, despite improvements in treatments and the development of new therapeutic opportunities. The prediction of outcome in heart failure is gradually moving towards a multiparametric approach in order to obtain more accurate models and to tailor the prognostic evaluation to the individual characteristics of a single subject. The Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score was developed 10 years ago from 2715 patients and subsequently validated in a different population. The score allows an accurate evaluation of the risk of heart failure patients using only six variables that include the evaluation of the exercise capacity (peak oxygen uptake and ventilation/CO production slope), blood samples (haemoglobin, Na, Modification of Diet in Renal Disease) and echocardiography (left ventricular ejection fraction). Over the following years, the MECKI score was tested taking into account therapies and specific markers of heart failure, and it proved to be a simple, useful tool for risk stratification and for therapeutic strategies in heart failure patients. The close connection between the centres involved and the continuous updating of the data allow the participating sites to propose substudies on specific subpopulations based on a common dataset and to put together and develop new ideas and perspectives.

摘要

尽管治疗方法有所改善,新的治疗机会也有所增加,但慢性心力衰竭相关的高发病率和低生存率仍然是一个巨大的挑战。心力衰竭预后的预测正逐渐朝着多参数方法发展,以便获得更准确的模型,并根据单个患者的个体特征调整预后评估。代谢运动测试数据与心脏和肾脏指数(MECKI)评分是 10 年前从 2715 名患者中开发出来的,并随后在不同人群中进行了验证。该评分仅使用包括运动能力评估(峰值摄氧量和通气/CO 产量斜率)、血液样本(血红蛋白、Na、肾脏病饮食改良)和超声心动图(左心室射血分数)在内的六个变量,即可对心力衰竭患者的风险进行准确评估。在随后的几年中,考虑到治疗方法和心力衰竭的特定标志物,对 MECKI 评分进行了测试,结果证明它是心力衰竭患者进行风险分层和治疗策略的一种简单、有用的工具。参与中心之间的密切联系和数据的不断更新,使得参与站点能够根据共同的数据集提出针对特定亚人群的子研究,并汇集和发展新的思路和观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc62/7691632/4232f6b334fe/10.1177_2047487320959010-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc62/7691632/4232f6b334fe/10.1177_2047487320959010-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc62/7691632/4232f6b334fe/10.1177_2047487320959010-fig1.jpg

相似文献

1
The MECKI score initiative: Development and state of the art.MECKI 评分倡议:发展与现状。
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):5-11. doi: 10.1177/2047487320959010.
2
Future developments in the MECKI score initiative.MECKI 评分计划的未来发展。
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):72-75. doi: 10.1177/2047487320962983.
3
Risk stratification in heart failure with mild reduced ejection fraction.心力衰竭伴轻度射血分数降低的风险分层。
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):59-64. doi: 10.1177/2047487320951104.
4
Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers.β受体阻滞剂治疗心力衰竭的预后:MECKI 评分组论文的经验教训。
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):65-71. doi: 10.1177/2047487320951109.
5
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis.代谢运动试验数据结合心脏和肾脏指标,MECEKI 评分:心力衰竭预后的多参数方法。
Int J Cardiol. 2013 Sep 10;167(6):2710-8. doi: 10.1016/j.ijcard.2012.06.113. Epub 2012 Jul 15.
6
The MECKI score initiative: a successful and ongoing story.梅基(MECKI)评分倡议:一个成功且仍在持续发展的故事。
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):3-4. doi: 10.1177/2047487320952692.
7
Comparison among different multiparametric scores for risk stratification in heart failure patients with reduced ejection fraction.比较不同的多参数评分在射血分数降低的心力衰竭患者中的风险分层。
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):12-18. doi: 10.1177/2047487320962990.
8
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study.代谢运动试验数据联合心脏和肾脏指数(MECKI)评分与心力衰竭预后的关系:一项验证性研究
Int J Cardiol. 2016 Jan 15;203:1067-72. doi: 10.1016/j.ijcard.2015.11.075. Epub 2015 Nov 10.
9
Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction.心肺运动试验在射血分数降低、中间范围和保留的心衰中的预后价值。
J Am Heart Assoc. 2017 Oct 31;6(11):e006000. doi: 10.1161/JAHA.117.006000.
10
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison.多参数预后评分在射血分数降低的慢性心力衰竭中的应用:长期比较。
Eur J Heart Fail. 2018 Apr;20(4):700-710. doi: 10.1002/ejhf.989. Epub 2017 Sep 26.

引用本文的文献

1
Ventilatory efficiency in cardiac amyloidosis-A systematic review and meta-analysis.心脏淀粉样变性中的通气效率——一项系统评价和荟萃分析
Physiol Rep. 2025 May;13(9):e70308. doi: 10.14814/phy2.70308.
2
Machine Learning-Based Risk Factor Analysis and Prediction Model Construction for the Occurrence of Chronic Heart Failure: Health Ecologic Study.基于机器学习的慢性心力衰竭发生风险因素分析及预测模型构建:健康生态学研究
JMIR Med Inform. 2025 Jan 31;13:e64972. doi: 10.2196/64972.
3
Heart failure outpatient clinics resources in Italy: a viewpoint of Italian Society of Cardiology organization.

本文引用的文献

1
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction.射血分数降低的心力衰竭患者运动时的性别和年龄归一化以及通气效率。
ESC Heart Fail. 2020 Feb;7(1):371-380. doi: 10.1002/ehf2.12582. Epub 2020 Jan 1.
2
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group.血清尿酸水平升高预示射血分数降低的轻度重度慢性心力衰竭患者预后不良。来自 MECKI 评分研究组的分析。
Eur J Intern Med. 2020 Feb;72:47-52. doi: 10.1016/j.ejim.2019.11.003. Epub 2019 Nov 29.
3
意大利心力衰竭门诊资源:意大利心脏病学会组织的观点
Heart Fail Rev. 2025 May;30(3):505-513. doi: 10.1007/s10741-024-10480-0. Epub 2025 Jan 8.
4
Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing-A multicentre study.通过心肺运动试验评估淀粉样心肌病的运动受限——一项多中心研究
ESC Heart Fail. 2025 Apr;12(2):1326-1335. doi: 10.1002/ehf2.15147. Epub 2024 Nov 14.
5
A matter of sex-persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study.心力衰竭伴射血分数降低的男性和女性中,MECKI评分预后能力的性别持续性预测价值:一项多中心研究。
Front Cardiovasc Med. 2024 Jul 3;11:1390544. doi: 10.3389/fcvm.2024.1390544. eCollection 2024.
6
Three Weeks of Inpatient Cardiac Rehabilitation Improves Metabolic Exercise Data Combined With Cardiac and Kidney Indexes Scores for Heart Failure With Reduced Ejection Fraction.为期三周的住院心脏康复可改善射血分数降低的心力衰竭患者的代谢运动数据,并结合心脏和肾脏指数评分。
Circ Rep. 2023 May 19;5(6):231-237. doi: 10.1253/circrep.CR-23-0016. eCollection 2023 Jun 9.
7
Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF.拉里萨心力衰竭风险评分与急性心力衰竭的死亡方式:来自REALITY-AHF研究的见解
J Clin Med. 2023 May 28;12(11):3722. doi: 10.3390/jcm12113722.
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction.
运动振荡通气与射血分数降低和中值心力衰竭患者的预后。
Eur J Heart Fail. 2019 Dec;21(12):1586-1595. doi: 10.1002/ejhf.1595. Epub 2019 Nov 28.
4
Anaerobic Threshold and Respiratory Compensation Point Identification During Cardiopulmonary Exercise Tests in Chronic Heart Failure.慢性心力衰竭患者心肺运动试验中无氧阈和呼吸补偿点的确定。
Chest. 2019 Aug;156(2):338-347. doi: 10.1016/j.chest.2019.03.013. Epub 2019 Mar 27.
5
Isocapnic buffering period: From physiology to clinics.等碳酸血症缓冲期:从生理学到临床。
Eur J Prev Cardiol. 2019 Jul;26(10):1107-1114. doi: 10.1177/2047487319829950. Epub 2019 Feb 12.
6
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years.随着时间推移的心力衰竭预后:在过去 20 年中,运动时耗氧量和通气效率的预后作用发生了怎样的变化。
Eur J Heart Fail. 2019 Feb;21(2):208-217. doi: 10.1002/ejhf.1364. Epub 2019 Jan 11.
7
Heart failure: the need for improved treatment and care.心力衰竭:改善治疗与护理的必要性。
Lancet. 2018 Aug 11;392(10146):451. doi: 10.1016/S0140-6736(18)31737-9. Epub 2018 Aug 9.
8
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation.β受体阻滞剂在慢性心力衰竭合并心房颤动患者中的疗效与剂量相关。
Int J Cardiol. 2018 Dec 15;273:141-146. doi: 10.1016/j.ijcard.2018.08.012. Epub 2018 Aug 6.
9
N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure.脑利钠肽前体 N 端片段与临床风险评分对慢性收缩性心力衰竭预后分层的比较。
Eur J Prev Cardiol. 2018 May;25(8):889-895. doi: 10.1177/2047487318766580. Epub 2018 Mar 23.
10
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study.醛固酮受体拮抗剂治疗心力衰竭:一项真实世界观察性研究。
ESC Heart Fail. 2018 Jun;5(3):267-274. doi: 10.1002/ehf2.12244. Epub 2018 Feb 4.